Coke’s Euro Boost, Southwest’s Seat Surrender, and AstraZeneca’s $50B Tariff Dodge
Coca-Cola topped Wall Street’s Q2 expectations, thanks entirely to Europe, while most other regions saw declining sales—highlighting deep shifts in global consumer demand. Southwest Airlines is abandoning its open seating model after half a century, aiming to generate $1.7 billion by 2026 with new seat assignments, fare types, and fees. Meanwhile, AstraZeneca is pouring $50 billion into U.S. facilities to avoid looming Trump-era pharma tariffs and secure future market share for blockbuster drugs. In AI news, OpenAI and SoftBank’s $500 billion Stargate project is stalling, with no facilities built and growing tensions between partners, raising questions about the feasibility of massive AI infrastructure plays.
🚀 Loving the show? Leave a 5-star rating & review on Apple Podcasts, Spotify, or YouTube to help more people discover it!
📩 Want to master your money in 5 minutes or less each week? Join the Master Money Newsletter → Sign up here
🎧 Like this show? You'll love our other podcast: The Personal Finance Podcast
📲 Follow Andrew Giancola on Social Media:
🔥 Thanks for tuning in! See you next episode.
Learn more about your ad choices. Visit megaphone.fm/adchoices
